Here and there someone will remark that they are LONG on RVX.  I suppose the question then is, well, ‘how long’ is that?  There are many scenarios.  Is it until after the announcement of positive topline results along with whatever bump the market rewards that news with?  Is it until after full data release?  A NASDAQ listing?  Or is it waiting until some BP makes an offer RVX and its shareholders can’t refuse?  Maybe it involves waiting even longer until all sorts of results on secondary indications are proven, or not?  Even if a BP buys RVX in some of combination of cash and shares, you can still be in the epigenetic game even though you’re now holding shares in some other company along with, presumably, a few dollars in the bank.

So, at what point does ‘being long’ transition to ‘being short’?  Obviously, everyone has his or her price depending on one’s own circumstance(s), and I understand that.  Neverthelesss, assuming a positive topline announcement and a market reward along the lines of what AMRN did ($15-$20/share), do you then just smile, sit back and wait for the full-data release?  Then once full data is released and it all looks great, do you then smile even more and again sit back and wait for a BP buyout?  And on it goes....

Given the somewhat unique nature of this company and it’s potential, I would be interested in knowing if there is any (general) consensus on what might be the smart play if you are ‘going LONG’ on RVX?  (BTW, I recognize that things don’t always move in a straight line and that any new information can change trading strategies at any point.  Again, I’m just talking in general terms.)